<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: common stock", fill: "#e1a95f"},
{source: "1: common stock", target: "1: risks inherent", fill: "#e1a95f"},
{source: "1: risks inherent", target: "1: risks described", fill: "#e1a95f"},
{source: "1: common stock", target: "3: Additional ", fill: "#b22222"},
{source: "3: Additional ", target: "3: immaterial may also impair", fill: "#b22222"},
{source: "3: immaterial may also impair", target: "3: operations", fill: "#b22222"},
{source: "3: Additional ", target: "5: trading price", fill: "#bdb76b"},
{source: "5: trading price", target: "5: common stock could decline", fill: "#bdb76b"},
{source: "5: trading price", target: "6: profitability depend on", fill: "#df00ff"},
{source: "6: profitability depend on", target: "6: market new products", fill: "#df00ff"},
{source: "6: profitability depend on", target: "9: significant delays", fill: "#ff0"},
{source: "9: significant delays", target: "9: introduction", fill: "#ff0"},
{source: "9: introduction", target: "9: introduce new products", fill: "#ff0"},
{source: "9: introduce new products", target: "9: additions", fill: "#ff0"},
{source: "9: additions", target: "9: future products", fill: "#ff0"},
{source: "9: future products", target: "9: market acceptance could", fill: "#ff0"},
{source: "9: market acceptance could", target: "9: profitability", fill: "#ff0"},
{source: "9: significant delays", target: "18: Although ", fill: "#9457eb"},
{source: "18: Although ", target: "18: historically suffered net losses", fill: "#9457eb"},
{source: "18: Although ", target: "20: net sales decline", fill: "#ecd540"},
{source: "20: net sales decline", target: "20: control expenses", fill: "#ecd540"},
{source: "20: control expenses", target: "20: profitability", fill: "#ecd540"},
{source: "20: net sales decline", target: "27: International ", fill: "#d70040"},
{source: "27: International ", target: "27: sales account", fill: "#d70040"},
{source: "27: sales account", target: "27: significant", fill: "#d70040"},
{source: "27: significant", target: "27: total net sales", fill: "#d70040"},
{source: "27: total net sales", target: "27: fiscal year", fill: "#d70040"},
{source: "27: International ", target: "29: denominated", fill: "#614051"},
{source: "29: denominated", target: "29: United States ", fill: "#614051"},
{source: "29: United States ", target: "29: significant currency risks", fill: "#614051"},
{source: "29: significant currency risks", target: "29: United States ", fill: "#614051"},
{source: "29: United States ", target: "29: dollar relative", fill: "#614051"},
{source: "29: dollar relative", target: "29: foreign currencies", fill: "#614051"},
{source: "29: foreign currencies", target: "29: international markets could", fill: "#614051"},
{source: "29: international markets could", target: "29: products less price competitive", fill: "#614051"},
{source: "29: products less price competitive", target: "29: such markets", fill: "#614051"},
{source: "29: denominated", target: "41: manufacturer", fill: "#fc89ac"},
{source: "41: manufacturer", target: "41: liability", fill: "#fc89ac"},
{source: "41: manufacturer", target: "START_HERE", fill: "#fc89ac"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Travel to meet</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Rally support</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Common_stock_dividend">Common stock dividend</a></td>
      <td>A common stock dividend is the dividend paid to common stock owners from the profits of the company.  Like other dividends, the payout is in the form of either cash or stock.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Stock_market">Stock market</a></td>
      <td>A stock market, equity market, or share market is the aggregation of buyers and sellers of stocks (also called shares), which represent ownership claims on businesses; these may include securities listed on a public stock exchange, as well as stock that is only traded privately, such as shares of private companies which are sold to investors through equity crowdfunding platforms. Investment is usually made with an investment strategy in mind.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Treasury_stock">Treasury stock</a></td>
      <td>A treasury stock or reacquired stock is stock which is bought back by the issuing company, reducing the amount of outstanding stock on the open market ("open market" including insiders' holdings). \nStock repurchases are used as a tax efficient method to put cash into shareholders' hands, rather than paying dividends, in jurisdictions that treat capital gains more favorably.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Convertible_bond">Convertible bond</a></td>
      <td>In finance, a convertible bond or  convertible note or convertible debt (or a convertible debenture if it has a maturity of greater than 10 years) is a type of bond that the holder can convert into a specified number of shares of common stock in the issuing company or cash of equal value.  It is a hybrid security with debt- and equity-like features.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_director">Operations director</a></td>
      <td>The role of operations director generally encompasses the oversight of operational aspects of company strategy with responsibilities to ensure operation information is supplied to the chief executive and the board of directors as well as external parties.\n\n\n== Description ==\nThe role of operations director can vary according to the size of a company, and at some companies many even encompass some or all the functions of a chief operating officer.The Institute of Directors of the United Kingdom defines the role as overseeing "all operational aspects of company strategy" and "responsible for the flow of operations information to the chief executive, the board and, where necessary, external parties such as investors or financial institutions".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Price">Price</a></td>
      <td>A prince is a male ruler (ranked below a king, grand prince, and grand duke) or a male member of a monarch's or former monarch's family. Prince is also a title of nobility (often highest), often hereditary, in some European states.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_Profitability_Analysis">Customer Profitability Analysis</a></td>
      <td>Customer Profitability Analysis (in short CPA) is a management accounting and a credit underwriting method, allowing businesses and lenders to determine the profitability of each customer or segments of customers, by attributing profits and costs to each customer separately. CPA can be applied at the individual customer level (more time consuming, but providing a better understanding of business situation) or at the level of customer aggregates / groups (e.g.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profit_(economics)">Profit (economics)</a></td>
      <td>An economic profit is the difference between the revenue a  commercial entity has received from its outputs and the opportunity costs of its inputs. It equals to total revenue minus total cost, including both explicit and implicit costs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Porter's_five_forces_analysis">Porter's five forces analysis</a></td>
      <td>Porter's Five Forces Framework is a method of analysing the operating environment of a competition of a business. It draws from industrial organization (IO) economics to derive five forces that determine the competitive intensity and, therefore, the attractiveness (or lack thereof) of an industry in terms of its profitability.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Net_income">Net income</a></td>
      <td>In business and accounting, net income (also total comprehensive income, net earnings, net profit, bottom line, sales profit, or credit sales) is an entity's income minus cost of goods sold, expenses, depreciation and amortization, interest, and taxes for an accounting period.It is computed as the residual of all revenues and gains less all expenses and losses for the period, and has also been defined as the net increase in shareholders' equity that results from a company's operations. It is different from gross income, which only deducts the cost of goods sold from revenue.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitability_analysis">Profitability analysis</a></td>
      <td>In cost accounting, profitability analysis is an analysis of the profitability of an organisation's output. Output of an organisation can be grouped into products, customers, locations, channels and/or transactions.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitability_index">Profitability index</a></td>
      <td>Profitability index (PI), also known as profit investment ratio (PIR) and value investment ratio (VIR), is the ratio of payoff to investment of a proposed project. It is a useful tool for ranking projects because it allows you to quantify the amount of value created per unit of investment.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Small_Is_Profitable">Small Is Profitable</a></td>
      <td>Small Is Profitable: The Hidden Economic Benefits of Making Electrical Resources the Right Size is a 2002 book by energy analyst Amory Lovins and others.  The book describes 207 ways in which the size of "electrical resources"—devices that make, save, or store electricity—affects their economic value.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitable_growth">Profitable growth</a></td>
      <td>Profitable Growth is the combination of profitability and growth, more precisely the combination of Economic Profitability and Growth of Free cash flows. Profitable growth is aimed at seducing the financial community; it emerged in the early 80s when shareholder value creation became firms’ main objective.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_profitability">Customer profitability</a></td>
      <td>Customer Profitability Analysis (in short CPA) is a management accounting and a credit underwriting method, allowing businesses and lenders to determine the profitability of each customer or segments of customers, by attributing profits and costs to each customer separately. CPA can be applied at the individual customer level (more time consuming, but providing a better understanding of business situation) or at the level of customer aggregates / groups (e.g.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_states_and_territories_of_the_United_States">List of states and territories of the United States</a></td>
      <td>The United States of America is a federal republic consisting of 50 states, a federal district (Washington, D.C., the capital city of the United States), five major territories, and various minor islands. The 48 contiguous states and Washington, D.C., are in North America between Canada and Mexico.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Internet">Internet</a></td>
      <td>In finance and economics, interest is payment from a borrower or deposit-taking financial institution to a lender or depositor of an amount above repayment of the principal sum (that is, the amount borrowed), at a particular rate. It is distinct from a fee which the borrower may pay the lender or some third party.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_other">Significant other</a></td>
      <td>The term significant other (SO) has different uses in psychology and in colloquial language. Colloquially "significant other" is used as a gender-neutral term for a person's partner in an intimate relationship without disclosing or presuming anything about marital status, relationship status, gender identity, or sexual orientation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_form">Significant form</a></td>
      <td>Significant form refers to an aesthetic theory developed by English art critic Clive Bell which specified a set of criteria for what qualified as a work of art.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_Others">Significant Others</a></td>
      <td>The term significant other (SO) has different uses in psychology and in colloquial language. Colloquially "significant other" is used as a gender-neutral term for a person's partner in an intimate relationship without disclosing or presuming anything about marital status, relationship status, gender identity, or sexual orientation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Simpsons">The Simpsons</a></td>
      <td>The Simpsons is an American animated sitcom created by Matt Groening for the Fox Broadcasting Company. The series is a satirical depiction of American life, epitomized by the Simpson family, which consists of Homer, Marge, Bart, Lisa, and Maggie.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_Mother">Significant Mother</a></td>
      <td>Significant Mother is an American television sitcom created by Erin Cardillo and Richard Keith. Starring Josh Zuckerman, Nathaniel Buzolic and Krista Allen, it premiered on The CW network on August 3 and ended its run on October 5, 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/United_States_dollar">United States dollar</a></td>
      <td>The United States dollar (symbol: $; code: USD; also abbreviated US$ or U.S. Dollar, to distinguish it from other dollar-denominated currencies; referred to as the dollar, U.S. dollar, American dollar, or colloquially buck) is the official currency of the United States and several other countries. The Coinage Act of 1792 introduced the U.S. dollar at par with the Spanish silver dollar, divided it into 100 cents, and authorized the minting of coins denominated in dollars and cents.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/United_States">United States</a></td>
      <td>The United States of America (U.S.A. or USA), commonly known as the United States (U.S. or US) or America, is a country primarily located in North America. It consists of 50 states, a federal district, five major unincorporated territories, 326 Indian reservations, and nine minor outlying islands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/President_of_the_United_States">President of the United States</a></td>
      <td>The president of the United States (POTUS) is the head of state and head of government of the United States of America. The president directs the executive branch of the federal government and is the commander-in-chief of the United States Armed Forces.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/United_States_Congress">United States Congress</a></td>
      <td>The United States Congress is the legislature of the federal government of the United States. It is bicameral, being composed of a lower body, the House of Representatives, and an upper body, the Senate.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Republican_Party_(United_States)">Republican Party (United States)</a></td>
      <td>The Republican Party, also referred to as the GOP ("Grand Old Party"), is one of the two major contemporary political parties in the United States, along with its main historic rival, the Democratic Party.\nThe GOP was founded in 1854 by anti-slavery activists who opposed the Kansas–Nebraska Act, which allowed for the potential expansion of chattel slavery into the western territories.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Democratic_Party_(United_States)">Democratic Party (United States)</a></td>
      <td>The Democratic Party is one of the two major contemporary political parties in the United States. It was founded in 1828 by supporters of Andrew Jackson, making it the world's oldest active political party.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_presidents_of_the_United_States">List of presidents of the United States</a></td>
      <td>The president of the United States is the head of state and head of government of the United States, indirectly elected to a four-year term by the American people through the Electoral College. The office holder leads the executive branch of the federal government and is the commander-in-chief of the United States Armed Forces.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Liability_insurance">Liability insurance</a></td>
      <td>Liability insurance (also called third-party insurance) is a part of the general insurance system of risk financing to protect the purchaser (the "insured") from the risks of liabilities imposed by lawsuits and similar claims and protects the insured if the purchaser is sued for claims that come within the coverage of the insurance policy.\nOriginally, individual companies that faced a common peril formed a group and created a self-help fund out of which to pay compensation should any member incur loss (in other words, a mutual insurance arrangement).</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>CRITICARE SYSTEMS INC /DE/      Item 1A  RISK FACTORS       An  investment in our <font color="blue">common stock</font> is subject to <font color="blue">risks inherent</font> in our     business, including the <font color="blue">risks described</font> below</td>
    </tr>
    <tr>
      <td>The <font color="blue">risks described</font> below are     not the only risks we face</td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font>risks that we do not yet know of or     that  we  currently  think are <font color="blue">immaterial may also impair</font> our business     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>If any of the events or <font color="blue">circumstances described</font> in the following     risks  actually occur, our business, <font color="blue">financial condition</font> or results of     <font color="blue">operations</font>  could be <font color="blue">materially adversely affected</font></td>
    </tr>
    <tr>
      <td>In such cases, the     <font color="blue">trading price</font> of our <font color="blue">common stock</font> could decline</td>
    </tr>
    <tr>
      <td>11       _________________________________________________________________       Risks Related to Our Business       Our net sales and <font color="blue"><font color="blue">profitability</font> <font color="blue">depend on</font></font> our ability to conceive, design     and <font color="blue">market <font color="blue">new products</font></font></td>
    </tr>
    <tr>
      <td>The <font color="blue">introduction</font> of <font color="blue">new products</font> is critical to our <font color="blue">growth strategy</font></td>
    </tr>
    <tr>
      <td>Our     <font color="blue">future success will depend</font> in large part upon our ability to conceive,     design, and <font color="blue">market <font color="blue">new products</font></font> and <font color="blue">upon market acceptance</font> of our existing     and <font color="blue">future products</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue"><font color="blue">significant</font> delays</font> in the <font color="blue">introduction</font> of, or the     failure to introduce, <font color="blue">new products</font> or <font color="blue">additions</font> to our existing product     lines or the failure of our existing or <font color="blue">future products</font> to maintain or     receive <font color="blue">market acceptance could</font> have a material adverse effect on our net     sales and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">future success will depend</font> on our ability to <font color="blue">compete effectively</font> in our     industry</td>
    </tr>
    <tr>
      <td>The  medical  equipment  industry  is  <font color="blue">highly competitive</font></td>
    </tr>
    <tr>
      <td>Many of our     <font color="blue">competitors</font> have greater financial and other resources, more established     brand <font color="blue">identities</font> and reputations, greater development <font color="blue">capabilities</font>, more     experience in <font color="blue">testing products</font> and obtaining <font color="blue"><font color="blue">regulatory</font> approvals</font>, and     larger and more experienced <font color="blue">sales forces than us</font></td>
    </tr>
    <tr>
      <td>In these respects, such     companies have a <font color="blue">competitive advantage over us</font></td>
    </tr>
    <tr>
      <td>In addition, <font color="blue">international</font>ly     there are many in-country <font color="blue">manufacturer</font>s that <font color="blue">supply duty</font> and tariff-free low     <font color="blue">cost monitors</font> that make it <font color="blue">difficult</font> for us to be <font color="blue">price competitive</font> in these     countries</td>
    </tr>
    <tr>
      <td>The <font color="blue">medical equipment market</font> is also experiencing increasing     customer concentration, due to the emergence of large <font color="blue">purchasing groups</font>,     which can increase the barriers for a small <font color="blue">company such as</font> Criticare</td>
    </tr>
    <tr>
      <td>If we     <font color="blue">cannot compete successfully</font> in the future, our net sales and <font color="blue">profitability</font>     <font color="blue">will likely decline</font></td>
    </tr>
    <tr>
      <td>We have a history of <font color="blue"><font color="blue">significant</font> losses</font> and may not be able to sustain     <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td><font color="blue">Although  </font>we  achieved  net income of dlra212cmam118 in fiscal 2006, we have     <font color="blue">historically suffered net losses</font>, including a net loss of $(422cmam245) for     fiscal 2005 and $(2cmam100cmam573) for fiscal 2004</td>
    </tr>
    <tr>
      <td>We achieved positive net     income in fiscal 2006 with net sales of dlra31dtta4 million, the <font color="blue">second highest</font>     level of net sales in our history</td>
    </tr>
    <tr>
      <td>If our <font color="blue">net sales decline</font>, or if we are     not able to <font color="blue">control expenses</font>, we may not be able to sustain or improve     <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>Our business may be <font color="blue">adversely affected by</font> the <font color="blue">highly regulated environment</font>     in which we operate</td>
    </tr>
    <tr>
      <td>Our products are subject to <font color="blue">regulation by</font> the <font color="blue">United States </font>Food and Drug     Administration  and comparable foreign <font color="blue"><font color="blue">government</font>al</font> <font color="blue">authorities</font></td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue">regulations</font> can be burdensome and may:         l       <font color="blue"><font color="blue">substantially</font> delay</font> or prevent the <font color="blue">introduction</font> of <font color="blue">new products</font>;         l       <font color="blue">materially increase</font> the costs of any new product <font color="blue">introduction</font>s;         l       <font color="blue">interfere with</font> or require cessation of <font color="blue">product <font color="blue">manufacturing</font></font> and marketing;     and         l       result in <font color="blue">product recalls</font></td>
    </tr>
    <tr>
      <td>Additionally, adoption of new <font color="blue">regulations</font> or <font color="blue">modifications</font> to applicable     <font color="blue">regulations</font> <font color="blue">could harm</font> our business</td>
    </tr>
    <tr>
      <td>Some of the <font color="blue">legislative</font> and <font color="blue">regulatory</font>     changes <font color="blue">may benefit us</font> and our <font color="blue">competitors</font>; other changes, however, could     have a material adverse effect on our business, <font color="blue">financial condition</font> and     results  of  operation  and/or  provide an advantage to certain of our     <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>12       _________________________________________________________________       Since we <font color="blue">sell product</font> in <font color="blue">foreign markets</font>, we are subject to <font color="blue">foreign currency</font>     and other <font color="blue">international</font> business risks that <font color="blue">could adversely affect</font> our     operating results</td>
    </tr>
    <tr>
      <td><font color="blue">International </font><font color="blue">sales account</font> for a <font color="blue">significant</font> portion of our <font color="blue">total net sales</font>     each  <font color="blue">fiscal year</font></td>
    </tr>
    <tr>
      <td>We expect that <font color="blue">international</font> sales will continue to     <font color="blue">constitute</font> a <font color="blue">significant</font> portion of our business</td>
    </tr>
    <tr>
      <td>Although our net sales are     primarily  <font color="blue">denominated</font> in <font color="blue">United States </font>dollars and are not subject to     <font color="blue">significant</font> currency risks, an increase in the value of the <font color="blue">United States </font>    <font color="blue">dollar relative</font> to <font color="blue">foreign currencies</font> in our <font color="blue">international</font> markets could     make our products less <font color="blue">price competitive</font> in <font color="blue">such markets</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">international</font>     sales are subject to the <font color="blue">risks inherent</font> in doing business abroad, including:         l       <font color="blue">complications</font> in <font color="blue">complying with</font> the laws and policies of the <font color="blue">United States </font>    and foreign <font color="blue"><font color="blue">government</font>s</font> <font color="blue">affecting</font> foreign trade, including duties, quotas,     taxes and export controls;         l       unexpected changes in <font color="blue">international</font> <font color="blue">regulatory</font> <font color="blue">requirements</font> and tariffs;         l       <font color="blue">difficult</font>ies in staffing and managing foreign <font color="blue">operations</font>;         l       political or economic changes, <font color="blue">especially</font> in developing nations; and         l       price controls and other restrictive actions by foreign <font color="blue"><font color="blue">government</font>s</font></td>
    </tr>
    <tr>
      <td>Our  reliance  on  offshore  <font color="blue">contract <font color="blue">manufacturing</font></font> makes our business     susceptible to <font color="blue">numerous risks</font> that <font color="blue">could affect</font> our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>In response to <font color="blue">pricing pressure</font>, in fiscal 2001 we <font color="blue">entered into agreements</font>     for offshore <font color="blue">contract <font color="blue">manufacturing</font></font></td>
    </tr>
    <tr>
      <td>We completed the transition of the     <font color="blue">offshore production</font> of <font color="blue">substantially</font> all of our <font color="blue">established product lines at</font>     the end of calendar 2001</td>
    </tr>
    <tr>
      <td>Currently, our offshore <font color="blue">manufacturing</font> is handled     by a <font color="blue">contract <font color="blue">manufacturing</font></font> firm in Taiwan that also has <font color="blue">manufacturing</font>     <font color="blue">capabilities</font>  in  China  and  the  US  Any <font color="blue">inability</font> of the offshore     <font color="blue">manufacturer</font> to deliver <font color="blue">products on</font> a <font color="blue">timely basis could</font> have a material     adverse effect on us</td>
    </tr>
    <tr>
      <td>Our reliance on offshore <font color="blue">contract <font color="blue">manufacturing</font></font> will subject us to numerous     risks, including the following:              l economic and <font color="blue">political instability</font> in the countries where the contract     <font color="blue">manufacturing</font> firms are located;          l restrictive actions by foreign <font color="blue"><font color="blue">government</font>s</font>;          l the laws and policies of the <font color="blue">United States </font><font color="blue">affecting</font> the <font color="blue">importation</font> of     goods (including duties, quotas and taxes);          <font color="blue">l production delays</font> and <font color="blue">cost overruns</font>;          <font color="blue">l quality control</font>; and          <font color="blue">l foreign trade</font> and tax laws</td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> a <font color="blue">major customer</font> for a <font color="blue">significant</font> portion of our sales</td>
    </tr>
    <tr>
      <td>We  also  had  a <font color="blue">receivable balance with</font> this customer of     <font color="blue">approximately</font>  dlra0dtta9  million  as  of  June 30, 2006, which represented     <font color="blue">approximately</font> 15prca of our <font color="blue">total receivables as</font> of that date</td>
    </tr>
    <tr>
      <td>An adverse     change in our <font color="blue">relationship with</font> or the <font color="blue">financial viability</font> of our largest     customer  could  have  a  material adverse effect on our net sales and     <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>13       _________________________________________________________________       As a <font color="blue">manufacturer</font> and marketer of medical equipment, we could experience     product <font color="blue">liability</font> claims</td>
    </tr>
    <tr>
      <td>The nature of our <font color="blue">products may expose us</font> to <font color="blue">significant</font> product <font color="blue">liability</font>     risks</td>
    </tr>
    <tr>
      <td>Although, we maintain product <font color="blue">liability</font> insurance, we can make no     assurance that we will be able to maintain this <font color="blue">insurance on</font> acceptable     terms or that the insurance will provide adequate coverage against product     <font color="blue">liability</font> claims</td>
    </tr>
    <tr>
      <td>A successful product <font color="blue">liability</font> claim <font color="blue">against us</font> in excess     of our <font color="blue">insurance coverage could</font> be <font color="blue">extremely damaging</font> to us</td>
    </tr>
    <tr>
      <td>Even if a     product  <font color="blue">liability</font>  claim  is  <font color="blue">without merit</font>, the claim <font color="blue">could harm</font> our     reputation  and  divert  managementapstas attention and <font color="blue">resources from</font> our     business</td>
    </tr>
    <tr>
      <td>Our <font color="blue">success depends on</font> our ability to protect our <font color="blue">intellectual property</font></td>
    </tr>
    <tr>
      <td>We rely on our patented and other <font color="blue"><font color="blue">proprietary</font> <font color="blue">technology</font></font> including:         l       our <font color="blue">sensor <font color="blue">technology</font></font>;         l       infrared specific anesthetic gas monitoring <font color="blue">technology</font>;         l       <font color="blue">UltraSync </font><font color="blue">signal processing software</font>; and         l       <font color="blue">disposable respiratory secretion filter system</font></td>
    </tr>
    <tr>
      <td>The  actions  <font color="blue">taken by us</font> to protect our <font color="blue"><font color="blue">proprietary</font> rights may</font> not be     adequate to <font color="blue">prevent imitation</font> of our products, processes or <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>We     can not assure you that:         l       our <font color="blue">proprietary</font> information will not <font color="blue">become known</font> to <font color="blue">competitors</font>;         l       others will not <font color="blue">independently</font> develop <font color="blue">substantially</font> equivalent or better     products that do not <font color="blue">infringe on</font> our <font color="blue">intellectual property</font> rights; or         l       others will not challenge or assert rights in, and ownership of, our patents     and other <font color="blue">proprietary</font> rights</td>
    </tr>
    <tr>
      <td>Health care cost containment programs <font color="blue">could adversely affect</font> our domestic     sales</td>
    </tr>
    <tr>
      <td>The cost of a <font color="blue">significant</font> portion of <font color="blue">medical care</font> in the <font color="blue">United States </font>and     in  <font color="blue">international</font>  markets  is funded by <font color="blue">government</font> or other insurance     programs</td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font><font color="blue">limits imposed by such programs on health care cost</font>     <font color="blue">reimbursements may further impair</font> the ability of hospitals and other health     <font color="blue">care providers</font> to <font color="blue">purchase equipment such as</font> our products and <font color="blue">could reduce</font>     our <font color="blue">domestic sales</font></td>
    </tr>
    <tr>
      <td>Our controls and procedures may be <font color="blue">ineffective</font>       Our <font color="blue">management regularly reviews</font> and updates our <font color="blue">internal control over</font>     financial reporting, <font color="blue">disclosure controls</font> and procedures, and corporate     <font color="blue">governance policies</font> and procedures</td>
    </tr>
    <tr>
      <td>Any system of controls, no matter how     <font color="blue">well designed</font> and operated, is <font color="blue">based partly on certain assumptions</font> and can     <font color="blue">provide only reasonable</font>, not absolute, assurances that the <font color="blue">objectives</font> of the     system are met</td>
    </tr>
    <tr>
      <td>Any failure or <font color="blue">circumvention</font> of our controls and procedures     or failure to comply with <font color="blue">regulations</font> related to controls and procedures     could have a material adverse effect on our business, results of <font color="blue">operations</font>,     and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>14       _________________________________________________________________       <font color="blue">Risks Related to an Investment </font>in our Common Stock       The <font color="blue">trading price</font> of our <font color="blue">common stock</font> has <font color="blue">been volatile</font> and investors in our     <font color="blue">common stock</font> may experience substantial losses</td>
    </tr>
    <tr>
      <td>The <font color="blue">market price</font> of our <font color="blue">common stock</font> has experienced <font color="blue">significant</font> <font color="blue">volatility</font>     from time to time</td>
    </tr>
    <tr>
      <td>There may be <font color="blue">volatility</font> in the <font color="blue">market price</font> of our common     stock due to factors that may or may not relate to our performance</td>
    </tr>
    <tr>
      <td>The     <font color="blue">trading price</font> of our <font color="blue">common stock</font> could decline or fluctuate in response to     a variety of <font color="blue">such factors</font>, including:             l       <font color="blue">announcements</font> and <font color="blue">developments</font> relating to the <font color="blue">consent solicitation</font> to   replace a majority of our <font color="blue">Board of Directors </font><font color="blue">started by</font> BlueLine Partners;         l       the timing of <font color="blue">announcements</font> by us or our <font color="blue">competitors</font> concerning <font color="blue">significant</font>     acquisitions, financial performance or the <font color="blue">introduction</font> of <font color="blue">new innovative</font>     products or services;         l       <font color="blue">fluctuations</font> in our quarterly operating results;         l       <font color="blue">fluctuations</font> in demand for our products;         l       <font color="blue">fluctuations</font> in <font color="blue">interest rates</font>;         l       substantial sales of our <font color="blue">common stock</font>; or         l       <font color="blue">general stock market</font> or other <font color="blue">economic conditions</font></td>
    </tr>
    <tr>
      <td>You may be unable to sell your stock at or above your <font color="blue">purchase price</font></td>
    </tr>
    <tr>
      <td>Various <font color="blue">restrictions</font> in our <font color="blue">certificate</font> of <font color="blue">incorporation</font> and by-laws, our     rights plan and <font color="blue">Delaware </font><font color="blue">law could prevent</font> or delay a change in control of     us which is not <font color="blue">supported by</font> our board of <font color="blue">directors</font></td>
    </tr>
    <tr>
      <td><font color="blue">Provisions </font>of our <font color="blue">certificate</font> of <font color="blue">incorporation</font> and by-laws may make it more     <font color="blue">difficult</font>  for a <font color="blue">third party</font> to <font color="blue">gain control</font> or acquire us without the     consent  of  our board of <font color="blue">directors</font>, even if such a <font color="blue"><font color="blue">transaction</font> may</font> be     perceived as beneficial to our <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td>These provisions include a     board of <font color="blue">directors</font> divided into three classes of <font color="blue">directors</font> serving staggered     terms of <font color="blue"><font color="blue">three years</font> each</font></td>
    </tr>
    <tr>
      <td>Each <font color="blue">currently outstanding</font> share of our <font color="blue">common stock</font> includes, and each     <font color="blue">newly issued</font> share of our <font color="blue">common stock</font> will include, <font color="blue">one preferred</font> share     purchase right</td>
    </tr>
    <tr>
      <td>The rights are attached to and <font color="blue">trade with</font> the shares of     <font color="blue">common stock</font> and <font color="blue">generally</font> are not exercisable</td>
    </tr>
    <tr>
      <td>The <font color="blue">rights will become</font>     exercisable the tenth business day after a person or group acquires 20prca or     more of our <font color="blue">common stock</font> or makes an offer to acquire 30prca or more of our     <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>When exercisable, each right entitles the holder to purchase     for dlra25, subject to adjustment, 1/100^th of a share of <font color="blue">preferred stock</font> for     each share of <font color="blue">common stock</font> owned</td>
    </tr>
    <tr>
      <td>The rights have anti-takeover effects and     <font color="blue">generally</font> will cause substantial dilution to a person or group that attempts     to acquire control of <font color="blue">us without conditioning</font> the <font color="blue">offer on either redemption</font>     of the rights or <font color="blue">amendment</font> of the rights to prevent this dilution</td>
    </tr>
    <tr>
      <td>The     <font color="blue">rights could</font> have the effect of delaying or preventing a change of control</td>
    </tr>
    <tr>
      <td>15       _________________________________________________________________       We are also subject to Section 203 of the <font color="blue">Delaware </font>General Corporation Law     which  prohibits  a merger, consolidation, asset sale or other similar     business <font color="blue">combination between</font> <font color="blue">Criticare </font>and any stockholder of 15prca or more of     our <font color="blue">common stock</font> for a period of <font color="blue">three years</font> after the stockholder acquires     15prca or more of our <font color="blue">common stock</font>, unless (1) the <font color="blue">transaction</font> is <font color="blue">approved by</font>     our board of <font color="blue">directors</font> before the stockholder acquires 15prca or more of our     <font color="blue">common stock</font>, (2) upon completing the <font color="blue">transaction</font> the stockholder owns at     least  85prca  of our <font color="blue">common stock</font> outstanding at the <font color="blue">commencement</font> of the     <font color="blue">transaction</font>, or (3) the <font color="blue">transaction</font> is <font color="blue">approved by</font> our board of <font color="blue">directors</font>     and the holders of 66 2/3prca of our <font color="blue">common stock</font> excluding shares of our     <font color="blue">common stock</font> owned by the stockholder</td>
    </tr>
  </tbody>
</table>